109 related articles for article (PubMed ID: 2175806)
21. Regulation of platelet-derived growth factor A and B chain gene expression in bone marrow stromal cells.
Abboud SL
J Cell Physiol; 1995 Aug; 164(2):434-40. PubMed ID: 7622589
[TBL] [Abstract][Full Text] [Related]
22. Activation of cyclic AMP-dependent protein kinase during canine lower esophageal sphincter relaxation.
Barnette MS; Grous M; Torphy TJ; Ormsbee HS
J Pharmacol Exp Ther; 1990 Mar; 252(3):1160-6. PubMed ID: 2156993
[TBL] [Abstract][Full Text] [Related]
23. Effects of inhibitors of intracellular messenger systems on amylase release from rat parotid gland.
Hashioka T; Kato M
Aichi Gakuin Dent Sci; 1990; 3():59-66. PubMed ID: 1718407
[TBL] [Abstract][Full Text] [Related]
24. Phorbol ester-induced expression of the common, low-affinity binding site for primary prostanoids in vascular smooth muscle cells.
Hanasaki K; Kishi M; Arita H
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():363-6. PubMed ID: 1825571
[No Abstract] [Full Text] [Related]
25. A selective effect of protein kinase C activators on noradrenaline release compared with subsequent contraction in canine isolated saphenous veins.
Takata Y; Ozawa J; Kato H
Br J Pharmacol; 1991 Apr; 102(4):955-61. PubMed ID: 1855124
[TBL] [Abstract][Full Text] [Related]
26. The relaxant action of jatrophone in rat portal vein. A comparison with protein kinase C inhibitors.
Silva AM; Brum RL; Calixto JB
Life Sci; 1995; 57(9):863-71. PubMed ID: 7630315
[TBL] [Abstract][Full Text] [Related]
27. The inhibition of phosphoenolpyruvate carboxykinase (guanosine triphosphate) gene expression by insulin is not mediated by protein kinase C.
Chu DT; Stumpo DJ; Blackshear PJ; Granner DK
Mol Endocrinol; 1987 Jan; 1(1):53-9. PubMed ID: 3331712
[TBL] [Abstract][Full Text] [Related]
28. Evidence that chloroethylclonidine can contract the dog saphenous vein via a protein kinase C-dependent mechanism.
Nunes JP; Mota A
Arch Int Pharmacodyn Ther; 1994; 327(2):142-51. PubMed ID: 7979824
[TBL] [Abstract][Full Text] [Related]
29. Contrasting effects of phorbol dibutyrate and phorbol myristate acetate in rabbit aorta.
Villalobos-Molina R; Ransanz V; Torres-Márquez ME; Hong E; García-Sáinz JA
Biochem Biophys Res Commun; 1990 Sep; 171(2):618-24. PubMed ID: 2403351
[TBL] [Abstract][Full Text] [Related]
30. Structure-activity relationships of phenothiazines and related drugs for inhibition of protein kinase C.
Aftab DT; Ballas LM; Loomis CR; Hait WN
Mol Pharmacol; 1991 Nov; 40(5):798-805. PubMed ID: 1944244
[TBL] [Abstract][Full Text] [Related]
31. Sangivamycin, a nucleoside analogue, is a potent inhibitor of protein kinase C.
Loomis CR; Bell RM
J Biol Chem; 1988 Feb; 263(4):1682-92. PubMed ID: 3338987
[TBL] [Abstract][Full Text] [Related]
32. Effects of selective inhibition of protein kinase C, cyclic AMP-dependent protein kinase, and Ca(2+)-calmodulin-dependent protein kinase on neurite development in cultured rat hippocampal neurons.
Cabell L; Audesirk G
Int J Dev Neurosci; 1993 Jun; 11(3):357-68. PubMed ID: 7689287
[TBL] [Abstract][Full Text] [Related]
33. Phorbol ester-induced expression of the common, low-affinity binding site for primary prostanoids in vascular smooth muscle cells.
Hanasaki K; Kishi M; Arita H
J Biol Chem; 1990 Mar; 265(9):4871-5. PubMed ID: 2318870
[TBL] [Abstract][Full Text] [Related]
34. Selective modulation of calcium-dependent myosin phosphorylation by novel protein kinase inhibitors, isoquinolinesulfonamide derivatives.
Hagiwara M; Inagaki M; Watanabe M; Ito M; Onoda K; Tanaka T; Hidaka H
Mol Pharmacol; 1987 Jul; 32(1):7-12. PubMed ID: 2955213
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of eukaryote protein kinases by isoquinoline and oxazine alkaloids.
Wang BH; Lu ZX; Polya GM
Planta Med; 1997 Dec; 63(6):494-8. PubMed ID: 9434598
[TBL] [Abstract][Full Text] [Related]
36. Effect of Ca2+/calmodulin-dependent protein kinase II inhibitors on the neurogenic cerebroarterial relaxation.
Toda N; Ayajiki K; Okamura T
Eur J Pharmacol; 1997 Dec; 340(1):59-65. PubMed ID: 9527507
[TBL] [Abstract][Full Text] [Related]
37. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C.
Hidaka H; Inagaki M; Kawamoto S; Sasaki Y
Biochemistry; 1984 Oct; 23(21):5036-41. PubMed ID: 6238627
[TBL] [Abstract][Full Text] [Related]
38. In vitro vasorelaxant effects of indolocarbazole and bis-indole protein kinase C inhibitors on rabbit renal arteries.
Fabre S; Prudhomme M
Arch Int Pharmacodyn Ther; 1995; 329(3):397-404. PubMed ID: 8546538
[TBL] [Abstract][Full Text] [Related]
39. A fluorescent protein kinase C inhibitor: 1-(1-hydroxy-5-isoquinolinylsulfonyl)piperazine.
Hagiwara M; Inagaki M; Takahashi J; Yoshida T; Hidaka H
Pharmacology; 1988; 36(6):365-70. PubMed ID: 3420158
[TBL] [Abstract][Full Text] [Related]
40. The intrinsic ATPase activity of protein kinase C is catalyzed at the active site of the enzyme.
Ward NE; O'Brian CA
Biochemistry; 1992 Jun; 31(25):5905-11. PubMed ID: 1535219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
